A Cancer Vaccine (Labvax 3(22)-23) and GM-CSF Alone or in Combination With Pembrolizumab for the Treatment of Advanced Stage Adenocarcinoma

NCT05101356 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

77

Enrollment

OTHER

Sponsor class

Conditions

Advanced Adenocarcinoma
Advanced Malignant Solid Neoplasm
Metastatic Adenocarcinoma
Metastatic Malignant Solid Neoplasm
Recurrent Adenocarcinoma
Recurrent Malignant Solid Neoplasm

Interventions

BIOLOGICAL: Antineoplastic Vaccine
BIOLOGICAL: Sargramostim
BIOLOGICAL: Pembrolizumab

Sponsor

Tianhong Li

Collaborators

[object Object]
[object Object]